RETRACTION: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3 (Retraction of Vol 8, Pg 34973, 2018)

被引：0
|
作者：
Fisher, Laura [1 ]
机构：
[1] Royal Soc Chem, Thomas Graham House,Sci Pk,Milton Rd, Cambridge CB4 0WF, England
来源：
RSC ADVANCES | 2021年 / 11卷 / 07期
关键词：
D O I：
10.1039/d1ra90019f
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：4166 / 4166
页数：1
相关论文
共 50 条
  • [1] RETRACTED: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3 (Retracted article. See vol. 11, pg. 4166, 2021)
    Yang, Shiming
    Chen, Zhi
    Fan, Daguang
    Zhang, Rui
    Zhang, Yuhong
    Wu, Shusheng
    [J]. RSC ADVANCES, 2018, 8 (61) : 34973 - 34983
  • [2] GPC1 Regulated by miR-96-5p, Rather than miR-182-5p, in Inhibition of Pancreatic Carcinoma Cell Proliferation
    Li, Chunlong
    Du, Xuefei
    Tai, Sheng
    Zhong, Xiangyu
    Wang, Zhidong
    Hu, Zhanliang
    Zhang, Lei
    Kang, Pengcheng
    Ji, Daolin
    Jiang, Xingming
    Zhou, Qingxin
    Wan, Ming
    Jiang, Guixing
    Cui, Yunfu
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (04) : 6314 - 6327
  • [3] RETRACTION: miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1
    Luo, X.
    He, X.
    Liu, X.
    Zhong, L.
    Hu, W.
    [J]. ONCOTARGETS AND THERAPY, 2022, 15 : 1407 - 1408
  • [4] RETRACTION: miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA (Retraction of Vol 479, Pg 901, 2016)
    Cui, Wenxian
    Li, Yuanguo
    Xu, Keqing
    Chen, Guijin
    Lu, Xiaoqun
    Duan, Qiuqin
    Kang, Zhirong
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (04) : 732 - 732
  • [5] RETRACTION: Effects of miR-138-5p and miR-204-5p on the migration and proliferation of gastric cancer cells by targeting EGFR (Retraction of Vol 39, Pg 2624, 2018)
    Wang, Yi
    Zhang, Haiyang
    Ge, Shaohua
    Fan, Qian
    Zhou, Likun
    Li, Hongli
    Bai, Ming
    Ning, Tao
    Liu, Rui
    Wang, Xia
    Deng, Ting
    Zhang, Le
    Ying, Guoguang
    Ba, Yi
    [J]. ONCOLOGY REPORTS, 2024, 51 (02)
  • [6] miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a (vol 11, 12, 2018)
    Cao, Man-Qing
    You, A-Bin
    Zhu, Xiao-Dong
    Zhang, Wei
    Zhang, Yuan-Yuan
    Zhang, Shi-Zhe
    Zhang, Kei-wei
    Cai, Hao
    Shi, Wen-Kai
    Li, Xiao-Long
    Li, Kang-Shuai
    Gao, Dong-Mei
    Ma, De-Ning
    Ye, Bo-Gen
    Wang, Cheng-Hao
    Qin, Cheng-Dong
    Sun, Hui-Chan
    Zhang, Ti
    Tang, Zhao-You
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [7] RETRACTION: miR-660-5p is associated with cell migration, invasion, proliferation and apoptosis in renal cell carcinoma (Retraction of Vol 17, Pg 2051, 2018)
    He, Tao
    Chen, Peijie
    Jin, Lu
    Hu, Jia
    Li, Yifan
    Zhou, Liang
    Yang, Shangqi
    Mao, Xiangming
    Gui, Yaoting
    Chen, Yun
    Lai, Yongqing
    [J]. MOLECULAR MEDICINE REPORTS, 2024, 29 (05)
  • [8] RETRACTION: MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells (Retraction of Vol 100, Pg 269, 2017)
    Xu, Bin
    Xu, Tangpeng
    Liu, Huali
    Min, Qian
    Wang, Shidong
    Song, Qibin
    [J]. PHARMACOLOGY, 2023, 108 (05) : 495 - 495
  • [9] RETRACTION: MiR-502-3P Suppresses Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Targeting SET (Retraction of Vol 9, Pg 3281, 2016)
    Jin, H.
    Yu, M.
    Lin, Y.
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 3177 - 3177
  • [10] Highly expressed miR-182-5p can promote preeclampsia progression by degrading RND3 and inhibiting HTR-8/SVneo cell invasion
    Fang, Y-N
    Huang, Z-L
    Li, H.
    Tan, W-B
    Zhang, Q-G
    Wang, L.
    Wu, J-L
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (20) : 6583 - 6590
12345